O
Ossiam Portfolio holdings
AUM
$8.89B
This Quarter Return
+14.99%
1 Year Return
+27.03%
3 Year Return
+125.2%
5 Year Return
+180.05%
10 Year Return
–
AUM
$2.87B
AUM Growth
+$2.87B
(+20%)
Cap. Flow
+$223M
Cap. Flow
% of AUM
7.8%
Top 10 Holdings %
Top 10 Hldgs %
38.02%
Holding
477
New
64
Increased
188
Reduced
163
Closed
58
Top Buys
| 1 |
Microsoft
MSFT
|
$83.1M |
| 2 |
Apple
AAPL
|
$60.7M |
| 3 |
T-Mobile US
TMUS
|
$41.6M |
| 4 |
Booking.com
BKNG
|
$31.2M |
| 5 |
Estee Lauder
EL
|
$28.5M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
$73.2M |
| 2 |
NVIDIA
NVDA
|
$60.4M |
| 3 |
Home Depot
HD
|
$55.3M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
$51.5M |
| 5 |
Goldman Sachs
GS
|
$38.1M |
Sector Composition
| 1 | Technology | 33.03% |
| 2 | Communication Services | 20.22% |
| 3 | Consumer Discretionary | 12.59% |
| 4 | Consumer Staples | 11.07% |
| 5 | Financials | 10.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
BioMarin Pharmaceuticals
BMRN
$11.3B
| $65K | ﹤0.01% |
743
+624
| +524% | +$54.6K |
|
377
Freeport-McMoran
FCX
$66.3B
| $61K | ﹤0.01% |
+2,343
| New | +$61K |
|
378
Vertex Pharmaceuticals
VRTX
$102B
| $61K | ﹤0.01% |
257
+205
| +394% | +$48.7K |
|
379
AptarGroup
ATR
$8.91B
| $59K | ﹤0.01% |
433
-3,181
| -88% | -$433K |
|
380
Aptiv
APTV
$17.3B
| $57K | ﹤0.01% |
439
-2,023
| -82% | -$263K |
|
381
Expedia Group
EXPE
$26.3B
| $56K | ﹤0.01% |
421
-3,067
| -88% | -$408K |
|
382
Illumina
ILMN
$15.2B
| $56K | ﹤0.01% |
155
+122
| +370% | +$44.1K |
|
383
lululemon athletica
LULU
$23.8B
| $56K | ﹤0.01% |
161
-725
| -82% | -$252K |
|
384
Flowers Foods
FLO
$3.09B
| $55K | ﹤0.01% |
+2,433
| New | +$55K |
|
385
Service Corp International
SCI
$10.9B
| $52K | ﹤0.01% |
1,049
-18,972
| -95% | -$940K |
|
386
DuPont de Nemours
DD
$31.6B
| $51K | ﹤0.01% |
718
+598
| +498% | +$42.5K |
|
387
Newell Brands
NWL
$2.64B
| $51K | ﹤0.01% |
+2,412
| New | +$51K |
|
388
Royal Gold
RGLD
$11.9B
| $51K | ﹤0.01% |
475
+433
| +1,031% | +$46.5K |
|
389
Ulta Beauty
ULTA
$23.8B
| $51K | ﹤0.01% |
178
-886
| -83% | -$254K |
|
390
Entergy
ETR
$38.9B
| $49K | ﹤0.01% |
988
-152
| -13% | -$7.54K |
|
391
Hilton Worldwide
HLT
$64.7B
| $48K | ﹤0.01% |
432
-21,531
| -98% | -$2.39M |
|
392
FMC
FMC
$4.63B
| $46K | ﹤0.01% |
398
-23,282
| -98% | -$2.69M |
|
393
Incyte
INCY
$17B
| $39K | ﹤0.01% |
446
-29,096
| -98% | -$2.54M |
|
394
Stryker
SYK
$149B
| $38K | ﹤0.01% |
154
+115
| +295% | +$28.4K |
|
395
Regeneron Pharmaceuticals
REGN
$59.8B
| $35K | ﹤0.01% |
72
-4,003
| -98% | -$1.95M |
|
396
Best Buy
BBY
$15.8B
| $32K | ﹤0.01% |
317
-3,077
| -91% | -$311K |
|
397
Citigroup
C
$175B
| $32K | ﹤0.01% |
513
-134,506
| -100% | -$8.39M |
|
398
Elevance Health
ELV
$72.4B
| $30K | ﹤0.01% |
94
-19,906
| -100% | -$6.35M |
|
399
Mettler-Toledo International
MTD
$26.1B
| $23K | ﹤0.01% |
+20
| New | +$23K |
|
400
Charles Schwab
SCHW
$175B
| $22K | ﹤0.01% |
411
-13,398
| -97% | -$717K |
|